Acute Myeloid Leukemia (AML) Treatment Market - Top Companies and Manufacturers

Companies Dominating the Acute Myeloid Leukemia Landscape

The acute myeloid leukemia market consists of several key players who are launching various strategic initiatives to expand their market position in the acute myeloid leukemia industry.

Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis International AG
Celgene Corporation
Bristol-Myers Squibb Company
Amgen Inc.
AbbVie Inc.
Eli Lilly and Company
GlaxoSmithKline plc
Sanofi-Aventis (Genzyme Corporation)
Sunesis Pharmaceutical Inc.

Browse Key Market Insights with Data Illustration:

Acute Myeloid Leukemia Market Size & Share, Growth Analysis 2037

In the News

Novartis International AG announced that it was successfully acquiring Cadent Therapeutics, a biotechnology company in clinical development for the manufacture of medicines for nervous and psychiatric diseases. The objective of this acquisition was to expand the range of medicines provided by Novartis for cancer and gene therapy, in particular AML therapies.
Bristol-Myers Squibb announced that its product, Onureg, had been approved by the FDA for maintenance therapy of AML in patients who were completely cured after aggressive chemotherapy. This medicine is the first and only oral medicine to be approved by the FDA for this use.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of acute myeloid leukemia is assessed at USD 3.7 billion.

The acute myeloid leukemia market size was valued at USD 3.41 billion in 2024 and is likely to cross USD 12.63 billion by 2037, expanding at more than 10.6% CAGR during the forecast period i.e., between 2025-2037. Rising owing to the aging population across the globe will boost the market growth..

North America industry is expected to dominate majority revenue share of 40% by 2037, due to growing R&D and product launches in the region.

The major players in the market include Pfizer Inc., Novartis International AG, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., AbbVie Inc., Eli Lilly and Company, GlaxoSmithKline plc, Sanofi-Aventis (Genzyme Corporation), Sunesis Pharmaceutical Inc.

Acute Myeloid Leukemia (AML) Treatment Market - Top Companies and Manufacturers

Companies Dominating the Acute Myeloid Leukemia Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the acute myeloid leukemia market?

Why is the acute myeloid leukemia sector gaining traction in near future?

Which region accounted for the largest acute myeloid leukemia industry share?

Who are the major acute myeloid leukemia players?